NASDAQ:OCUL News 6 December 2025

(OCUL) Stock Soars on Accelerated Wet AMD NDA – Price, Forecast & Risk Analysis as of December 9, 2025

All figures and opinions reflect information available on December 9, 2025 and may change over time. This article is for informational purposes only and is not investment advice. OCUL Stock Today: A 52‑Week High After a Single Press Release Ocular

9 December 2025

Top Pre‑Market Gainers Today (December 8, 2025): Confluent, Carvana and Biotech Names Lead Fed‑Week Rally

U.S. stock futures are edging higher on Monday, December 8, 2025, as traders head into a pivotal Federal Reserve meeting widely expected to deliver this year’s final rate cut. Nasdaq 100 futures are up around a quarter of a percent,

8 December 2025

Biotech Stocks · Financial News · Investing · NASDAQ:ACLX · NASDAQ:AVGO · NASDAQ:CFLT · NASDAQ:DYN · NASDAQ:FULC · NASDAQ:HOOD · NASDAQ:KYMR · NASDAQ:MU · NASDAQ:OCUL · NASDAQ:RGNX · NASDAQ:TER · NYSE:ALB · NYSE:CVNA · NYSE:IBM · Pre-Market Movers · Stock Market

Ocular Therapeutix (OCUL) Stock News Today: Price, Forecast and Analysis as AXPAXLI NDA Plan Emerges

As of the close on Friday, December 5, 2025, Ocular Therapeutix, Inc. (NASDAQ: OCUL) finished regular trading at $12.58 per share, up about 1.2% on the day, with after‑hours quotes on some platforms briefly touching the $14 area. StockAnalysis+1 The

6 December 2025

Biotechnology · Financial Forecasts · Investment Analysis · NASDAQ:OCUL · Pharma News · Stock Market

NASDAQ:OCUL News 6 December 2025 - 9 December 2025

(OCUL) Stock Soars on Accelerated Wet AMD NDA – Price, Forecast & Risk Analysis as of December 9, 2025

Top Pre‑Market Gainers Today (December 8, 2025): Confluent, Carvana and Biotech Names Lead Fed‑Week Rally

Ocular Therapeutix (OCUL) Stock News Today: Price, Forecast and Analysis as AXPAXLI NDA Plan Emerges